Stay updated on Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial page.

Latest updates to the Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial page
- Check3 days agoChange DetectedThe site revision has been updated to v3.5.3, replacing the previous v3.5.2. This appears to be a minor platform release and does not alter the study information or its presentation on the page.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedAdded Revision: v3.5.2; removed Revision: v3.5.0.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check39 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3. This update does not alter the study details or page content.SummaryDifference0.0%

- Check81 days agoChange DetectedRevision: v3.4.2 was added; the earlier notice about government funding status (v3.4.1) was removed.SummaryDifference0.3%

- Check88 days agoChange DetectedAdded a public notice about potential disruptions due to a lapse in government funding and the NIH Clinical Center's operating status, with a link to opm.gov. Updated the site revision to v3.4.1, replacing v3.4.0.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial page.